Prevention of human adenocarcinoma with CpG-ODN in a mouse model

RJ HigginsM McKisicPJ DickinsonGrowth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexesCancer Immunol Immunother53338344200410.1007/s00262-003-0447-y14618278

AF CarpentierL ChenF MaltontiJY DelattreOligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in miceCancer Res5954295432199910554011

T JakobPS WalkerAM KriegMC UdeyJC VogelActivation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNAJ Immunol1613042304919989743369

AF CarpentierJ XieK MokhtariJY DelattreSuccessful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifsClin Cancer Res624692473200010873101

AD SandlerH ChiharaG KobayashiCpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastomaCancer Res633943992003

LD ShultzF IshikawaDL GreinerHumanized mice in translational biomedical researchNat Rev Immunol7118130200710.1038/nri201717259968

SE WrightKA Rewers-FelkinsIS QuinlinAdoptive immunotherapy of mucin1 expressing adenocarcinomas with mucin1 stimulated human peripheral blood mononuclear cellsInt J Mol Med94014042002

MZ DewanM WatanabeK TerashimaPrompt tumor formation and maintenance of constitutive NF-κB activity of multiple myeloma cells in NOD/SCID/γCnull miceCancer Sci95564568200415245591

P BeckhoveF SchützIJ DielEfficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid miceInt J Cancer105444453200310.1002/ijc.1112512712433

M ItoH HiramatsuK KobayashiNOD/SCID/γ mouse: an excellent recipient mouse model for engraftment of human cellsBlood100317531822002

Z BallasW RasmussenA KriegInduction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNAJ Immunol1571840184519968757300

WE SeamanM SleisengerE ErikssonGC KooDepletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunityJ Immunol1384539454419873584981

J VollmerR WeeratnaP PayetteCharacterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activitiesEur J Immunol34251262200410.1002/eji.20032403214971051

AM KriegAK YiS MatsonCpG motifs in bacterial DNA trigger direct B-cell activationNature374546549199510.1038/374546a07700380

AM KriegAn innate immune defense mechanism based on the recognition of CpG motifs in microbial DNAJ Lab Clin Med128128133199610.1016/S0022-2143(96)90004-98765208

S MocciSA DalrympleR NishinakamuraR MurrayThe cytokine stew and innate resistance to L. monocytogenesImmunol Rev158107114199710.1111/j.1600-065X.1997.tb00996.x9314078

JV ReynoldsJ ShouH ChoiR SigalMM ZieglerJM DalyThe influence of natural killer cells in neuroblastomaArch Surg124235239198910.1001/archsurg.1989.014100201090182492800

A PessionA PreteF LocatelliImmunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastomaBr J Cancer78528533199810.1038/bjc.1998.5279716039

TR JonesN Obaldia IIIRA GramzinskiSynthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeysVaccine1730653071199910.1016/S0264-410X(99)00145-010462241

HL DavisII SupartoRR WeeratnaJumintartoCpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutansVaccine1819201924200010.1016/S0264-410X(99)00443-010699341

RD WeeratnaMJ McCluskieY XuHL DavisCpG DNA induces stronger immune responses with less toxicity than other adjuvantsVaccine1817551762200010.1016/S0264-410X(99)00526-510699323

T TokunagaS YamamotoK NambaA synthetic single-stranded DNA, poly(dG,dC), induces interferon-alpha/beta and -gamma, augments natural killer activity, and suppresses tumor growthJpn J Cancer Res79682686198810.1111/j.1349-7006.1988.tb02222.x2457572

S YamamotoT YamamotoT KataokaE KuramotoO YanoT TokunagaUnique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activityJ Immunol148407240761992

J CohenIL-12 deaths: explanation and a puzzleScience270908199510.1126/science.270.5238.908a7481785

H HemmiO TakeuchiT KawaiA toll-like receptor recognizes bacterial DNANature408740745200010.1038/3504712311130078